Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids
- 1 January 2016
- book chapter
- Published by Springer Nature
- Vol. 1382, 133-149
Abstract
More than one hundred naturally occurring variants of adeno-associated virus (AAV) have been identified, and this library has been further expanded by an array of techniques for modification of the viral capsid. AAV capsid variants possess unique antigenic profiles and demonstrate distinct cellular tropisms driven by differences in receptor binding. AAV capsids can be chemically modified to alter tropism, can be produced as hybrid vectors that combine the properties of multiple serotypes, and can carry peptide insertions that introduce novel receptor-binding activity. Furthermore, directed evolution of shuffled genome libraries can identify engineered variants with unique properties, and rational modification of the viral capsid can alter tropism, reduce blockage by neutralizing antibodies, or enhance transduction efficiency. This large number of AAV variants and engineered capsids provides a varied toolkit for gene delivery to the CNS and retina, with specialized vectors available for many applications, but selecting a capsid variant from the array of available vectors can be difficult. This chapter describes the unique properties of a range of AAV variants and engineered capsids, and provides a guide for selecting the appropriate vector for specific applications in the CNS and retina.Keywords
This publication has 133 references indexed in Scilit:
- Mutation in the platelet-derived growth factor receptor alpha inhibits adeno-associated virus type 5 transductionVirology, 2012
- Receptors and tropisms of envelope virusesCurrent Opinion in Virology, 2011
- Glycated AAV Vectors: Chemical Redirection of Viral Tissue TropismBioconjugate Chemistry, 2011
- Naturally occurring singleton residues in AAV capsid impact vector performance and illustrate structural constraintsGene Therapy, 2009
- Directed evolution of adeno-associated virus for glioma cell transductionJournal of Neuro-Oncology, 2009
- Preferential labeling of inhibitory and excitatory cortical neurons by endogenous tropism of adeno-associated virus and lentivirus vectorsNeuroscience, 2009
- Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expressionVirology, 2008
- Tropism and toxicity of adeno-associated viral vector serotypes 1, 2, 5, 6, 7, 8, and 9 in rat neurons and glia in vitroVirology, 2008
- Novel AAV serotypes for improved ocular gene transferThe Journal of Gene Medicine, 2008
- Specific AAV serotypes stably transduce primary hippocampal and cortical cultures with high efficiency and low toxicityBrain Research, 2008